Phototherapeutic options for vitiligo

Dermatological Phototherapy and Photodiagnostic Methods

Volumn , Issue , 2009, Pages 151-183

  Ortel, Bernhard ^a   Petronic Rosic, Vesna ^a   Calzavara Pinton, Piergiacomo ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Azienda Spedali Civili di Brescia ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051739748     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-36693-5_7     Document Type: Chapter

References (159)

1. Abdel-Fattah A, Aboul-Enein MN, Wassel GM, El-Menshawi BS (1982) An approach to the treatment of vitiligo by khellin. Dermatologica 165:136-140
2. Ada S, Sahin S, Boztepe G, Karaduman A, Kolemen F (2005) No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo. Photo-dermatol Photoimmunol Photomed 21:79-83
3. Africk J, Fulton J (1971) Treatment of vitiligo with topical trimethylpsoralen and sunlight. Br J Dermatol 84:151-156
4. Agrawal K, Agrawal A (1995) Vitiligo: surgical repigmentation of leukotrichia. Dermatol Surg 21:711-715
5. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ (1994) Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 131:160-165
6. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208-214
7. Antoniou C, Schulpis H, Michas T, Katsambas A, Frajis N, Tsagaraki S, Stratigos J (1989) Vitiligo therapy with oral and topical phenylalanine with UVA exposure. Int J Dermatol 28:545-547
8. Antoniou C, Katsambas A (1992) Guidelines for the treatment of vitiligo. Drugs 43:490-498
9. Asawanonda P, Anderson RR, Chang Y, Taylor CR (2000) 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol 136:619-624
10. Austin M (2004) Fighting and living with vitiligo. J Am Acad Dermatol 51:S7-8
11. Aydogan K, Turan OF, Onart S, Karadogan SK, Tunali S (2006) Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol 31:110-113
12. Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB (1993) An immuno-histological study of cutaneous lymphocytes in vitiligo. J Pathol 170:149-155
13. Baltas E, Csoma Z, Ignacz F, Dobozy A, Kemeny L (2002) Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 138:1619-1620
14. Barman KD, Khaitan BK, Verma KK (2004) A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo. Dermatol Surg 30:49-53
15. Baysal V, Yildirim M, Erel A, Kesici D (2003) Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur Acad Dermatol Venereol 17:299-302
16. Beissert S, Schwarz T (1999) Mechanisms involved in ultraviolet light-induced immunosup-pression. J Investig Dermatol Symp Proc 4:61-64
17. Beissert S, Schwarz T (2002) Role of immunomodulation in diseases responsive to phototherapy. Methods 28:138-144
18. Bernd A, Ramirez-Bosca A, Huber H, Diaz Alperi J, Thaci D, Sewell A, Quintanilla Almagro E, Holzmann H (1995) In vitro studies on the immunomodulating effects of polypodium leucotomos extract on human leukocyte fractions. Arzneimittelforschung 45:901-904
19. Bhawan J (1997) Mel-5: a novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffn-embedded sections. Melanoma Res 7:43-48
20. Brazzelli V, Prestinari F, Castello M, Bellani E, Roveda E, Barbagallo T, Borroni G (2005) Useful treatment of vitiligo in 10 children with UV-B narrowband (311 nm). Pediatr Derma-tol 22:257-261
21. Buckley DA, Rogers S (1996) Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 21:43-45
22. Burkhart CG, Burkhart CN (1999) Phenylalanine with U VA for the treatment of vitiligo needs more testing for possible side effects. J Am Acad Dermatol 40:1015
23. Calanchini-Postizzi E, Frenk E (1987) Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin. Dermatologica 174:266-271
24. Calzavara-Pinton PG, Carlino A, Manfredi E, Semeraro F, Zane C, De Panflis G (1994) Ocular side effects of PUVA-treated patients refusing eye sun protection. Acta Derm Venereol Suppl (Stockh) 186:164-165
25. Camacho F, Mazuecos J (1999) Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience. Arch Dermatol 135:216-217
26. Carlie G, Ntusi NB, Hulley PA, Kidson SH (2003) KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro. Br J Dermatol 149:707-717
27. Castanedo-Cazares JP, Lepe V, Moncada B (2003) Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band. Photodermatol Photoimmunol Pho-tomed 19:35-36
28. Cherif F, Azaiz MI, Ben Hamida A, Ben O, Dhari A (2003) Calcipotriol and PUVA as treatment for vitiligo. Dermatol Online J 9:4
29. Cormane RH, Siddiqui AH, Westerhof W, Schutgens RB (1985) Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res 277:126-130
30. Coskun B, Saral Y, Turgut D (2005) Topical 0.05% clobetasol propionate versus 1% pime-crolimus ointment in vitiligo. Eur J Dermatol 15:88-91
31. Cox NH, Jones SK, Downey DJ, Tuyp EJ, Jay JL, Moseley H, Mackie RM (1987) Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Br J Dermatol 116:145-152
32. Cui J, Bystryn JC (1995) Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol 131:314-318
33. de Gruijl FR (1999) Skin cancer and solar UV radiation. Eur J Cancer 35:2003-2009
34. de Leeuw J, van der Beek N, Maierhofer G, Neugebauer WD (2003) A case study to evaluate the treatment of vitiligo with khellin encapsulated in l-phenylalanin stabilized phosphatidyl-choline liposomes in combination with ultraviolet light therapy. Eur J Dermatol 13:474-477
35. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Turner ML, Webster SB, Whitaker DC, Lowery BJ, Nordlund JJ, Grimes PE, Halder RM, Minus HR (1996) Guidelines of care for vitiligo. American Academy of Dermatology. J Am Acad Dermatol 35:620-626
36. Duschet P, Schwarz T, Pusch M, Gschnait F (1989) Marked increase of liver transaminases after khellin and UVA therapy. J Am Acad Dermatol 21:592-594
37. El Mofty (1948) A preliminary clinical report on the treatment of leukoderma with Ammi majus Linn. J Royal Egypt Med Assoc 31:651-655
38. Falabella R (1988) Treatment of localized vitiligo by autologous minigrafting. Arch Derma-tol 124:1649-1655
39. Falabella R (2003) Surgical treatment of vitiligo: why, when and how. J Eur Acad Dermatol Venereol 17:518-520
40. Falabella R (2005) Surgical approaches for stable vitiligo. Dermatol Surg 31:1277-1284
41. Fitzpatrick TB, Ortonne J-P (2003) Normal skin color and general considerations of pigmentary disorders. In: Freedberg IM, Eisen AZ, Wolff K et al (eds) Dermatology in general medicine. McGraw-Hill, New York
42. Frenk E (1986) Treatment of vitiligo. Hautarzt 37:1-5
43. Gargoom AM, Duweb GA, Elzorghany AH, Benghazil M, Bugrein OO (2004) Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res 24:11-14
44. Gauthier Y, Andre MC, Taieb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16:322-332
45. Gokhale BB, Parakh AP (1983) Cyclophosphamide in vitiligo. Indian J Dermatol 28:7-10
46. Gonzalez S, Pathak MA, Cuevas J, Villarrubia VG, Fitzpatrick TB (1997) Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and pso-ralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol Photoimmunol Photomed 13:50-60
47. Grimes PE, Minus HR, Chakrabarti SG, Enterline J, Halder R, Gough JE, Kenney JA Jr (1982) Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Derma-tol 7:771-778
48. Grimes PE (2004) White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol 51:S5-7
49. Grimes PE (2005) New insights and new therapies in vitiligo. JAMA 293:730-735
50. Grundmann-Kollmann M, Ludwig R, Zollner TM, Ochsendorf F, Thaci D, Boehncke WH, Krutmann J, Kaufmann R, Podda M (2004) Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis. J Am Acad Dermatol 50:734-739
51. Halder RM, Battle EF, Smith EM (1995) Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol 131:734-735
52. Halder RM (1997) Childhood vitiligo. Clin Dermatol 15:899-906
53. Handa S, Pandhi R, Kaur I (2001) Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients. J Dermatol 28:461-466
54. Handa S, Dogra S (2003) Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol 20:207-210
55. Hann SK, Cho MY, Im S, Park YK (1991) Treatment of vitiligo with oral 5-methoxypsoralen. J Dermatol 18:324-329
56. Hann SK, Im S, Bong HW, Park YK (1995) Treatment of stable vitiligo with autologous epidermal grafting and PUVA. J Am Acad Dermatol 32:943-948
57. Hann SK, Lee HJ (1996) Segmental vitiligo: clinical fndings in 208 patients. J Am Acad Dermatol 35:671-674
58. Hann SK, Kim YS, Yoo JH, Chun YS (2000) Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol 42:589-596
59. Harrist TJ, Pathak MA, Mosher DB, Fitzpatrick TB (1984) Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. Natl Cancer Inst Monogr 66:191-196
60. Hartmann A, Lurz C, Hamm H, Brocker EB, Hofmann UB (2005) Narrow-band UVB 311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol 44:736-742
61. Hofer A, Kerl H, Wolf P (2001) Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol 11:225-229
62. Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P (2005) Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol 152:981-985
63. Hong SB, Park HH, Lee MH (2005) Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. J Korean Med Sci 20:273-278
64. Hultsch T, Kapp A, Spergel J (2005) Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 211:174-187
65. Ibbotson SH, Bilsland D, Cox NH, Dawe RS, Diffey B, Edwards C, Farr PM, Ferguson J, Hart G, Hawk J, Lloyd J, Martin C, Moseley H, McKenna K, Rhodes LE, Taylor DK (2004) An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatol-ogy Group Workshop report. Br J Dermatol 151:283-297
66. Kanwar AJ, Dogra S, Parsad D (2004) Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin Exp Dermatol 29:589-592
67. Kanwar AJ, Dogra S (2005) Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol 30:332-336
68. Kawalek AZ, Spencer JM, Phelps RG (2004) Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg 30:130-135
69. Kenney JA Jr (1971) Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation. Arch Dermatol 103:475-480
70. Kim SM, Lee HS, Hann SK (1999) The effcacy of low-dose oral corticosteroids in the treatment of vitiligo patients. Int J Dermatol 38:546-550
71. Kim YJ, Chung BS, Choi KC (2001) Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis. Dermatol Surg 27:969-970
72. Koga M, Tango T (1988) Clinical features and course of type A and type B vitiligo. Br J Der-matol 118:223-228
73. Kose O, Riza Gur A, Kurumlu Z, Erol E (2002) Calcipotriol ointment versus clobetasol ointment in localized vitiligo: an open, comparative clinical trial. Int J Dermatol 41:616-618
74. Koster W, Wiskemann A (1990) Phototherapy with UV-B in vitiligo. Z Hautkr 65:1022-1024, 1029
75. Kostovic K, Pasic A (2005) New treatment modalities for vitiligo: focus on topical immunomodulators. Drugs 65:447-459
76. Kovacs SO (1998) Vitiligo. J Am Acad Dermatol 38:647-666; quiz 667-668
77. Kreuter A, Gambichler T, Avermaete A, Jansen T, Altmeyer P, von Kobyletzki G (2001) Localized vitiligo successfully treated with cream-psoralen + ultraviolet A. J Eur Acad Dermatol Venereol 15:357-358
78. Kuiters GR, Hup JM, Siddiqui AH, Cormane RH (1986) Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. J Trop Med Hyg 89:149-155
79. Kullavanijaya P, Lim HW (2004) Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photodermatol Photoimmunol Photomed 20:248-251
80. Kumari J (1984) Vitiligo treated with topical clobetasol propionate. Arch Dermatol 120:631-635
81. Kwok YK, Anstey AV, Hawk JL (2002) Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study. Clin Exp Dermatol 27:104-110
82. Le Poole C, Boissy RE (1997) Vitiligo. Semin Cutan Med Surg 16:3-14
83. Le Poole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W (1993) Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2:145-153
84. Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK (1993) Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100:816-822
85. Le Poole IC, Wankowicz-Kalinska A, van den Wijngaard RM, Nickoloff BJ, Das PK (2004) Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc 9:68-72
86. Leone G, Iacovelli P, Paro Vidolin A, Picardo M (2003) Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol Venereol 17:531-537
87. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB (2003) A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 139:581-585
88. Lerner AB, Halaban R, Klaus SN, Moellmann GE (1987) Transplantation of human melano-cytes. J Invest Dermatol 89:219-224
89. Liu JB, Li M, Yang S, Gui JP, Wang HY, Du WH, Zhao XY, Ren YQ, Zhu YG, Zhang XJ (2005) Clinical profles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 30:327-331
90. Lotti TM, Menchini G, Andreassi L (1999) UV-B radiation microphototherapy. An elective treatment for segmental vitiligo. J Eur Acad Dermatol Venereol 13:102-108
91. Mai DW, Omohundro C, Dijkstra JW, Bailin PL (1998) Childhood vitiligo successfully treated with bath PUVA. Pediatr Dermatol 15:53-55
92. Majumder PP, Nordlund JJ, Nath SK (1993) Pattern of familial aggregation of vitiligo. Arch Dermatol 129:994-998
93. Miescher G (1930) Das Problem des Lichtschutzes und der Lichtgewöhnung. Strahlentherapie 35:403
94. Mofty ME, Zaher H, Esmat S, Youssef R, Shahin Z, Bassioni D, Enani GE (2001) PUVA and PUVB in vitiligo-are they equally effective? Photodermatol Photoimmunol Photomed 17:159-163
95. Mohammad A (1989) Vitiligo repigmentation with anapsos (Polypodium leucotomos). Int J Dermatol 28:479
96. Morliere P, Honigsmann H, Averbeck D, Dardalhon M, Huppe G, Ortel B, Santus R, Duber-tret L (1988) Phototherapeutic, photobiologic, and photosensitizing properties of khellin. J Invest Dermatol 90:720-724
97. Mosher DB, Parrish JA, Fitzpatrick TB (1977) Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol 97:669-679
98. Na G Y, Seo SK, Choi SK (1998) Single hair grafting for the treatment of vitiligo. J Am Acad Dermatol 38:580-584
99. Natta R, Somsak T, Wisuttida T, Laor L (2003) Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 49:473-476
100. Njoo MD, Das PK, Bos JD, Westerhof W (1999) Association of the Kobner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 135:407-413
101. Njoo MD, Bos JD, Westerhof W (2000) Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 42:245-253
102. Njoo MD, Vodegel RM, Westerhof W (2000) Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol 42:760-769
103. Nordlund JJ, Taylor NT, Albert DM, Wagoner MD, Lerner AB (1981) The prevalence of vitiligo and poliosis in patients with uveitis. J Am Acad Dermatol 4:528-536
104. Norris DA, Kissinger RM, Naughton GM, Bystryn JC (1988) Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Der-matol 90:783-789
105. Orecchia G, Perfetti L (1992) Photochemotherapy with topical khellin and sunlight in viti-ligo. Dermatology 184:120-123
106. Orecchia G, Malagoli P (1995) Topical photochemotherapy with 5-methoxypsoralen in viti-ligo. J Invest Dermatol 104:694
107. Ortel B, Tanew A, Honigsmann H (1988) Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 18:693-701
108. Ortel B, Perl S, Kinaciyan T, Calzavara-Pinton PG, Honigsmann H (1993) Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypso-ralen in the treatment of psoriasis. J Am Acad Dermatol 29:736-740
109. Ortonne J-P, Bahadoran P, Fitzpatrick TB, Mosher DB, Hori Y (2003) Hypomelanoses and hypermelanoses. In: Freedberg IM, Eisen AZ, Wolff K et al (eds) Dermatology in general medicine. McGraw-Hill, New York
110. Park HS, Lee YS, Chun DK (2003) Squamous cell carcinoma in vitiligo lesion after longterm PUVA therapy. J Eur Acad Dermatol Venereol 17:578-580
111. Park S, Albert DM, Bolognia JL (1992) Ocular manifestations of pigmentary disorders. Der-matol Clin 10:609-622
112. Parsad D, Saini R, Verma N (1998) Combination of PUVAsol and topical calcipotriol in viti-ligo. Dermatology 197:167-170
113. Parsad D, Saini R, Nagpal R (1999) Calcipotriol in vitiligo: a preliminary study. Pediatr Der-matol 16:317-320
114. Pasricha JS, Khaitan BK (1993) Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol 32:753-757
115. Pasricha JS, Khera V (1994) Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol 33:584-587
116. Passeron T, Ostovari N, Zakaria W, Fontas E, Larrouy JC, Lacour JP, Ortonne JP (2004) Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol 140:1065-1069
117. Patel DC, Evans AV, Hawk JL (2002) Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol 27:641-644
118. Pathak MA, Mosher DB, Fitzpatrick TB, Parrish JA (1980) Relative effectiveness of three psoralens and sunlight in repigmentation of 365 vitiligo patients. J Invest Dermatol 74:252
119. Pathak MA, Mosher DB, Fitzpatrick TB (1984) Safety and therapeutic effectiveness of 8-methoxypsoralen, 4, 5′, 8-trimethylpsoralen, and psoralen in vitiligo. Natl Cancer Inst Monogr 66:165-173
120. Pathak MA, Fitzpatrick TB (1992) The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B 14:3-22
121. Phan GQ, Attia P, Steinberg SM, White DE, Rosenberg SA (2001) Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. J Clin Oncol 19:3477-3482
122. Pianigiani E, Risulo M, Andreassi A, Taddeucci P, Ierardi F, Andreassi L (2005) Autologous epidermal cultures and narrow-band ultraviolet B in the surgical treatment of vitiligo. Derma-tol Surg 31:155-159
123. Porter J, Beuf AH, Lerner A, Nordlund J (1987) Response to cosmetic disfgurement: patients with vitiligo. Cutis 39:493-494
124. Porter JR, Beuf AH, Lerner AB, Nordlund JJ (1990) The effect of vitiligo on sexual relationships. J Am Acad Dermatol 22:221-222
125. Radakovic-Fijan S, Furnsinn-Friedl AM, Honigsmann H, Tanew A (2001) Oral dexametha-sone pulse treatment for vitiligo. J Am Acad Dermatol 44:814-817
126. Radmanesh M (2000) Depigmentation of the normally pigmented patches in universal viti-ligo patients by cryotherapy. J Eur Acad Dermatol Venereol 14:149-152
127. Reyes E, Jaen P, Heras Ede L, Eusebio E, Carrion F, Cuevas J, Gonzalez S, Villarrubia VG, Alvarez-Mon M (2006) Systemic immunomodulatory effects of Polypodium leucoto-mos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study. J Dermatol Sci 41:213-216
128. Ronnerfalt L, Lydahl E, Wennersten G, Jahnberg P, Thyresson-Hok M (1982) Ophthalmolog-ical study of patients undergoing long-term PUVA therapy. Acta Derm Venereol 62:501-505
129. Rosenbach T, Wellenreuther U, Nurnberger F, Czarnetzki BM (1993) [Treatment of vitiligo with phenylalanine and UV-A]. Hautarzt 44:208-209
130. Schallreuter KU, Pittelkow MP (1988) Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin. Arch Dermatol Res 280:137-139
131. Schallreuter KU, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, Berger J (1994) Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 188:269-275
132. Schallreuter KU, Wood JM, Pittelkow MR, Gutlich M, Lemke KR, Rodl W, Swanson NN, Hitzemann K, Ziegler I (1994) Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 263:1444-1446
133. Schallreuter KU, Wood JM, Lemke KR, Levenig C (1995) Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 190:223-229
134. Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M (2002) Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocata-lase (PC-KUS). Int J Dermatol 41:482-487
135. Scherschun L, Kim JJ, Lim HW (2001) Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 44:999-1003
136. Schulpis CH, Antoniou C, Michas T, Strarigos J (1989) Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediatr Dermatol 6:332-335
137. Sehgal VN (1971) Oral trimethylpsoralen in vitiligo in children: a preliminary report. Br J Dermatol 85:454-456
138. Siddiqui AH, Stolk LM, Bhaggoe R, Hu R, Schutgens RB, Westerhof W (1994) L-phenylala-nine and U VA irradiation in the treatment of vitiligo. Dermatology 188:215-218
139. Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, Chamlin SL, Paller AS (2004) Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol 51:760-766
140. Skouge J, Morison WL (1995) Vitiligo treatment with a combination of PUVA therapy and epidermal autografts. Arch Dermatol 131:1257-1258
141. Spencer JM, Nossa R, Ajmeri J (2002) Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 46:727-731
142. Srinivas CR, Shenoi SD, Balachandran C (1990) Acceleration of repigmentation in vitiligo by topical minoxidil in patients on photochemotherapy. Int J Dermatol 29:154-155
143. Stern RS, Laird N (1994) The carcinogenic risk of treatments for severe psoriasis. Photo-chemotherapy Follow-up Study. Cancer 73:2759-2764
144. Stolk L, Siddiqui AH, Cormane RH (1981) Serum levels of trimethylpsoralen after oral administration. Br J Dermatol 104:443-445
145. Studniberg HM, Weller P (1993) PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 29:1013-1022
146. Szekeres E, Morvay M (1985) Repigmentation of vitiligo macules treated topically with Efu-dix cream. Dermatologica 171:55-59
147. Taneja A, Trehan M, Taylor CR (2003) 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 42:658-662
148. Tham SN, Gange RW, Parrish JA (1987) Ultraviolet-B treatment of psoriasis in patients with concomitant vitiligo. Arch Dermatol 123:26-27
149. Thiele B, Steigleder GK (1987) Repigmentation treatment of vitiligo with L-phenylalanine and U VA irradiation. Z Hautkr 62:519-523
150. Tjioe M, Otero ME, van de Kerkhof PC, Gerritsen MJ (2005) Quality of life in vitiligo patients after treatment with long-term narrowband ultraviolet B phototherapy. J Eur Acad Der-matol Venereol 19:56-60
151. Travis LB, Silverberg NB (2004) Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr Dermatol 21:495-498
152. Tsuji T, Hamada T (1983) Topically administered fuorouracil in vitiligo. Arch Dermatol 119:722-727
153. Valkova S, Trashlieva M, Christova P (2004) Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol 29:180-184
154. van der Leun JC (1984) UV-carcinogenesis. Photochem Photobiol 39:861-868
155. Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M (2004) No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a frst retrospective study. Acta Derm Venereol 84:370-374
156. Westerhof W, Nieuweboer-Krobotova L (1997) Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 133:1525-1528
157. Westerhof W, Njoo MD, Schallreuter KU (1997) Vitiligo. Hautarzt 48:677-693; quiz 693
158. Wildfang IL, Jacobsen FK, Thestrup-Pedersen K (1992) PUVA treatment of vitiligo: a retrospective study of 59 patients. Acta Derm Venereol 72:305-306
159. Yagi S, Hanawa S, Morishima T (1983) Bowen disease and bowenoid lesion arising on vit-iliginous skin during longterm phototherapy. Nippon Hifuka Gakkai Zasshi 93:741-745